Pharma Capital
Showing 6 of 6
Name Market Market Cap Share Price Daily Share Movement
m_pharma_5739c0416b400.png M Pharmaceutical CSE £3.29m £0.03 11.11% ico_glass.png
neph.png NephroGenex NASDAQ £- £- - ico_glass.png
vaxil.png Vaxil TSX-V £- £- - ico_glass.png
ventripoint.png VentriPoint Diagnostics TSX-V £- £- - ico_glass.png
volition-logo.png VolitionRx NYSE £- £- - ico_glass.png
zynerba-pharmaceuticals.png Zynerba Pharmaceuticals NASDAQ £- £- - ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.